The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

Shuo Meng

doi:10.1016/j.brainresbull.2026.111775

journal article Open Access Apr 01, 2026

The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

Shuo Meng

Brain Research Bulletin Vol. 237 pp. 111775 · Elsevier BV

View at Publisher Save 10.1016/j.brainresbull.2026.111775

Topics

No keywords indexed for this article. Browse by subject →

References

73

[1]

Anastassova "New indole-3-propionic acid and 5-methoxy-indole carboxylic acid derived hydrazone hybrids as multifunctional neuroprotectors" Antioxidants (2023) 10.3390/antiox12040977

[2]

Anon, 2019. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease. Neuron 2019, 103, 627-641.e7, doi: 10.1016/j.neuron.2019.05.035. 10.1016/j.neuron.2019.05.035

[3]

Badawy "Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects" Int J. Tryptophan Res. (2017) 10.1177/1178646917691938

[4]

Barroso "The aryl hydrocarbon receptor and the gut–brain axis" Cell Mol. Immunol. (2021) 10.1038/s41423-020-00585-5

[5]

Bhattacharyya "Lipopolysaccharide from gut microbiota modulates α-Synuclein aggregation and alters its biological function" ACS Chem. Neurosci. (2019) 10.1021/acschemneuro.8b00733

[6]

Bhidayasiri Front. Neurol. (2024)

[7]

Boya "Diversity of the tryptophanase gene and its evolutionary implications in living organisms" Microorganisms (2021) 10.3390/microorganisms9102156

[8]

Staging of brain pathology related to sporadic Parkinson’s disease

Heiko Braak, Kelly Del Tredici, Udo Rüb et al.

Neurobiology of Aging 2003 10.1016/s0197-4580(02)00065-9

[9]

Cai "NLRP3 inflammasome and gut microbiota–brain axis: a new perspective on white matter injury after intracerebral hemorrhage" Neural Regen. Res. (2025) 10.4103/nrr.nrr-d-24-00917

[10]

Chen "Alteration of gut microbial metabolites in the systemic circulation of patients with Parkinson’s disease" J. Park. ’S. Dis. (2022)

[11]

Dehhaghi "Microorganisms, tryptophan metabolism, and kynurenine pathway: a complex interconnected loop influencing human health status" Int J. Tryptophan Res. (2019) 10.1177/1178646919852996

[12]

Denman "Gut-brain axis: gut dysbiosis and psychiatric disorders in alzheimer’s and Parkinson’s disease" Front. Neurosci. (2023) 10.3389/fnins.2023.1268419

[13]

Dodd "A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites" Nature (2017) 10.1038/nature24661

[14]

Duan "Relationship between short-chain fatty acids and Parkinson’s disease: a review from pathology to clinic" Neurosci. Bull. (2024) 10.1007/s12264-023-01123-9

[15]

Gao "Tryptophan metabolism: a link between the gut microbiota and brain" Adv. Nutr. (2020) 10.1093/advances/nmz127

[16]

Gao "Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism" Front. Cell Infect. Microbiol. (2018) 10.3389/fcimb.2018.00013

[17]

Gordon "Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice" Sci. Transl. Med. (2018) 10.1126/scitranslmed.aah4066

[18]

Horsager "Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study" Brain (2020) 10.1093/brain/awaa238

[19]

Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer

Yingjian Hou, Jing Li, Shuhuan Ying

Metabolites 2023 10.3390/metabo13111166

[20]

Irmler "Ability of Latilactobacillus Curvatus FAM25164 to Produce Tryptamine: Identification of a Novel Tryptophan Decarboxylase" Food Microbiol (2023) 10.1016/j.fm.2023.104343

[21]

Jia "The Role of Microbial Indole Metabolites in Tumor" Gut Microbes (2024) 10.1080/19490976.2024.2409209

[22]

Kalyanaraman "Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: relevance to Parkinson’s disease and therapeutic implications" Redox Biol. (2024) 10.1016/j.redox.2024.103092

[23]

Kenna "Changes in the gut microbiome and predicted functional metabolic effects in an Australian Parkinson’s disease cohort" Front. Neurosci. (2021) 10.3389/fnins.2021.756951

[24]

Khan "Indole-3-Carbinol Regulates Microglia Homeostasis and Protects the Retina from Degeneration" J. Neuroinflamm. (2020) 10.1186/s12974-020-01999-8

[25]

Killinger "The Vermiform Appendix Impacts the Risk of Developing Parkinson’s Disease" Sci. Transl. Med (2018) 10.1126/scitranslmed.aar5280

[26]

Kim "Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease" Neuron (2019) 10.1016/j.neuron.2019.05.035

[27]

Konopelski "Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals’ Health and Disease" Int. J. Mol. Sci. (2022) 10.3390/ijms23031222

[28]

Konopelski "Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals’ Health and Disease" Int. J. Mol. Sci. (2022) 10.3390/ijms23031222

[29]

Krueger "Comparative Analysis of Parkinson’s and Inflammatory Bowel Disease Gut Microbiomes Reveals Shared Butyrate-Producing Bacteria Depletion" npj Park. Dis. (2025) 10.1038/s41531-025-00894-4

[30]

Li "Structural Changes of Gut Microbiota in Parkinson’s Disease and Its Correlation with Clinical Features" Sci. China Life Sci. (2017) 10.1007/s11427-016-9001-4

[31]

Loh "Microbiota–Gut–Brain Axis and Its Therapeutic Applications in Neurodegenerative Diseases" Sig Transduct. Target Ther. (2024) 10.1038/s41392-024-01743-1

[32]

Luan "Comprehensive Urinary Metabolomic Profiling and Identification of Potential Noninvasive Marker for Idiopathic Parkinson’s Disease" Sci. Rep. (2015) 10.1038/srep13888

[33]

Madella "Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation" Toxins (2022) 10.3390/toxins14090645

[34]

The Brain-Gut-Microbiome Axis

Clair R. Martin, Vadim Osadchiy, Amir Kalani et al.

Cellular and Molecular Gastroenterology and Hepato... 2018 10.1016/j.jcmgh.2018.04.003

[35]

Mohamad "Neuroprotective Effects of Indole-3-Carbinol on the Rotenone Rat Model of Parkinson’s Disease: Impact of the SIRT1-AMPK Signaling Pathway" Toxicol. Appl. Pharm. (2022) 10.1016/j.taap.2021.115853

[36]

Montgomery "Lactobacillus Reuteri Tryptophan Metabolism Promotes Host Susceptibility to CNS Autoimmunity" Microbiome (2022) 10.1186/s40168-022-01408-7

[37]

Morais "α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in Mice" npj Park. Dis. (2024) 10.1038/s41531-024-00816-w

[38]

Nacarino-Palma "Loss of Aryl Hydrocarbon Receptor Favors K-RasG12D-Driven Non-Small Cell Lung Cancer" Cancers (2021) 10.3390/cancers13164071

[39]

Ngui "Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?" Molecules (2020) 10.3390/molecules25102427

[40]

Nishiwaki "Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder" mSystems (2020) 10.1128/msystems.00797-20

[41]

Nishiwaki "Short Chain Fatty Acids-Producing and Mucin-Degrading Intestinal Bacteria Predict the Progression of Early Parkinson’s Disease" NPJ Park. Dis. (2022) 10.1038/s41531-022-00328-5

[42]

Palacios "Appendectomy and Risk of Parkinson’s Disease in Two Large Prospective Cohorts of Men and Women" Mov. Disord. (2018) 10.1002/mds.109

[43]

Pan "Uncovering the Specificity and Predictability of Tryptophan Metabolism in Lactic Acid Bacteria with Genomics and Metabolomics" Front. Cell. Infect. Microbiol (2023) 10.3389/fcimb.2023.1154346

[44]

Park "Regulation of Common Neurological Disorders by Gut Microbial Metabolites" Exp. Mol. Med (2021) 10.1038/s12276-021-00703-x

[45]

Poesen "The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites" PLOS ONE (2015) 10.1371/journal.pone.0140820

[46]

Qi "Z. Indole-3-Propionic Acid, a Functional Metabolite of Clostridium Sporogenes, Promotes Muscle Tissue Development and Reduces Muscle Cell Inflammation" Int J. Mol. Sci. (2021) 10.3390/ijms222212435

[47]

Rajkovaca Latic "Association of Intestinal Inflammation and Permeability Markers with Clinical Manifestations of Parkinson’s Disease" Park. Relat. Disord. (2024) 10.1016/j.parkreldis.2024.106948

[48]

Reichardt "Phylogenetic Distribution of Three Pathways for Propionate Production within the Human Gut Microbiota" ISME J. (2014) 10.1038/ismej.2014.14

[49]

Renaldi "p-Cresol and p-Cresyl Sulphate Boost Oxidative Stress: A Systematic Review of Recent Evidence" Basic Clin. Pharm. Toxicol. (2025) 10.1111/bcpt.70065

[50]

Roager "Microbial Tryptophan Catabolites in Health and Disease" Nat. Commun. (2018) 10.1038/s41467-018-05470-4

Showing 50 of 73 references

Metrics

0

Citations

73

References

Details

Published: Apr 01, 2026
Vol/Issue: 237
Pages: 111775
License: View

Authors

S

Shuo Meng

Cite This Article

Shuo Meng (2026). The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review. Brain Research Bulletin, 237, 111775. https://doi.org/10.1016/j.brainresbull.2026.111775

The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

You May Also Like